Navigation Links
K-V Pharmaceutical Announces Updated Makena® Performance Metrics
Date:11/8/2011

onsent Decree" of our Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2011, including:(a) the consent decree between the Company and the FDA and the Company's suspension in 2008 and 2009 of the production and shipment and the nationwide recall of all of the products that it formerly manufactured, as well as the related material adverse effect on our revenue, assets and liquidity and capital resources;(b) the agreement between the Company and the Office of Inspector General of the U.S. Department of Health and Human Services ("HHS OIG") to resolve the risk of potential exclusion of the Company from participation in federal healthcare programs; and(c) our ability to comply with the plea agreement between a  now-dissolved subsidiary of the Company and the U.S. Department of Justice;(5) the availability of raw materials and/or products manufactured for the Company under contract manufacturing agreements with third parties;(6) risks that the Company may not ultimately prevail in, or that insurance proceeds, if any, will be insufficient to cover potential losses that may arise from, litigation discussed in Note 16—"Commitments and Contingencies—Litigation and Governmental Inquiries" of the Notes to the Consolidated Financial Statements included in Part I, Item 1 of our Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2011, including: (a) the series of putative class action lawsuits alleging violations of the federal securities laws by the Company and certain individuals;  (b) product liability lawsuits; (c) lawsuits pertaining to indemnification and employment agreement obligations involving the Company and its former Chief Executive Officer; (d) the possibility that the pending lawsuits and investigation by HHS OIG regarding potential false claims under Title 42 of the U.S. Code could result in significant civil fines or penalties, including exclusion from participation in federal healthcare programs such as Me
'/>"/>
SOURCE K-V Pharmaceutical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. S1P1 Lead Compounds, Assets Generated by Epix Pharmaceuticals, Inc. and Amgen, Will Be Offered for Sale at a December 8, 2011 Sealed Bid Sale. Target Rationale for S1P1 Agonists Explained.
2. New Video Discusses Dust Collection Equipment for Pharmaceutical Containment
3. Critical Alerts For Barrick Gold, Molycorp, Lockheed Martin, Teva Pharmaceutical, and Tenaris Released By Seven Summits Research
4. Onyx Pharmaceuticals Announces Data Presentations Highlighting Carfilzomib at 53rd American Society of Hematology Annual Meeting
5. Anadys Pharmaceuticals Reports Third Quarter 2011 Financial Results and Highlights
6. Planet Biopharmaceuticals, Inc. Divests Assets of Allergy Control Products, Inc.
7. Ancor Acquires WellSpring Pharmaceutical Corporation
8. Inovio Pharmaceuticals Reports 2011 Third Quarter Financial Results
9. Savient Pharmaceuticals Announces New Data Surrounding KRYSTEXXA® and the Impact of Refractory Chronic Gout at the American College of Rheumatology Meeting
10. Global Pharm Holdings Group, Inc. Completes Acquisition of Qingdao Likang Pharmaceutical Co., Ltd.
11. Vanda Pharmaceuticals Reports Third Quarter 2011 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... SAN FRANCISCO , July 31, 2014 /PRNewswire/ ... ) and Aspira Scientific ( Milpitas, California ... joint venture to develop and commercialize new fluorination ... biologically active molecules has benefited from the use ... metabolism, and combine lipophilicity with polarity to improve ...
(Date:7/31/2014)... For the first time, cardiac surgeons, medical ... the SynCardia temporary Total Artificial Heart in a peer ... the Journal of Visualized Experiments website. ... the SynCardia Total Artificial Heart implantation   goo.gl/2OZyKW ... the SynCardia Total Artificial Heart," a July 18, 2014 ...
(Date:7/31/2014)... July 31, 2014 The Galien Foundation today ... Galien USA Awards. The Prix ... and recognizes the technical, scientific and clinical research skills ... This year brings the highest number of nominees since ... . Nominees include biomedical products across three categories ...
Breaking Medicine Technology:Catylix, Inc. and Aspira Scientific Announce Joint Venture to Commercialize New Fluorination Technologies 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 3The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 2The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 3The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 4The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 5
... ... ... EST Q It,s an interesting time, so we really are eager to talk to you about,especially ... I,d love your overall assessment from -- of what,s,been happening on the Hill, like Pelosi,s leadership and ...
... Data from 11 PROCRIT(R) (Epoetin alfa),studies will be presented at the ... - 11, 2007., The data will provide ... blood supply of limiting the use of ... chemotherapy-induced anemia (CIA); -- the use of PROCRIT in extended ...
Cached Medicine Technology:Interview of the Vice President 2Interview of the Vice President 3Interview of the Vice President 4Interview of the Vice President 5Interview of the Vice President 6Interview of the Vice President 7Interview of the Vice President 8Interview of the Vice President 9Interview of the Vice President 10Interview of the Vice President 11Interview of the Vice President 12Interview of the Vice President 13Interview of the Vice President 14Interview of the Vice President 15Interview of the Vice President 16PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 2PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 3PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 4PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 5PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 6PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 7PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 8PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 9
(Date:7/31/2014)... 2014 Cosmetic Town is a new ... to consumers considering cosmetic treatments. The site features ... goal is to educate prospective patients on a variety ... a validated referral system that helps patients find cosmetic ... their respective fields. , Cosmetic Town started its ...
(Date:7/31/2014)... Denver, Colorado (PRWEB) July 31, 2014 ... commonly doctors recommend pain killers for this health problem. ... reveals that this new program was created by Peter ... purpose to help sufferers from all over the world ... , If people wish to view pros and ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Current residents ... abuse treatment program in Flagstaff, AZ, learn to kayak ... of equipment and paddle strokes in preparation for next ... , "I think that [the kayaking course] teaches [residents] ... they struggle with in their early part of their ...
(Date:7/31/2014)... CarePoint Health is proud to ... has joined our network, CarePoint Health Medical Group. ... Hundreds of highly skilled and experienced physicians comprise ... top doctors and practices in Hudson County, representing ... represents CarePoint Health’s commitment to provide the highest ...
(Date:7/31/2014)... 31, 2014 DocbookMD , a ... Haas and Tim Gueramy, announced the on-boarding of six ... According to Dr. Tim Gueramy, CEO of DocbookMD, most ... physician leaders from each one had been using the ... benefit for their respective organizations to adopt the HIPAA-secure ...
Breaking Medicine News(10 mins):Health News:The New Doctors’ Directory, Cosmetic Town Does the Research for Consumers of Plastic Surgeries 2Health News:Neuropathy Miracle Review Reveals Peter Bansby's Unique Cure Method 2Health News:Back2Basics Substance Abuse Residents Take Kayaking Class for the First Time 2Health News:Dr. Rizvi Joins CarePoint Health Medical Group 2Health News:Physician Demand for Integrated Communication Platform Drives DocbookMD Growth 2
... FAIRFIELD, Calif., Dec. 3 With Sutter Regional ... Medical,Campus, community residents now have access to a ... location., The three-story, 69,000-square-foot care center, located ... location, providing an enhanced,environment and room for growth. ...
... be to blame, researchers say , MONDAY, Dec. 3 (HealthDay ... than other males to develop the eating disorder anorexia nervosa, ... to female sex hormones in the womb may be associated ... researchers. , "Anorexia nervosa is approximately 10 times more common ...
... Australia has identified an upper limit for ALT that is ... could facilitate targeted interventions for the youths in this group, ... liver disease. The study is in the December issue of ... behalf of the American Association for the Study of Liver ...
... Seniors who take a close look at,the Part ... reap,handsome savings next year. Many Medicare HMO and PPO ... deductibles with either complete or,partial coverage throughout the "gap" ... bills until reaching $4,050 in out-of-pocket costs).,HealthMetrix Research Inc. ...
... Patrick O,Connell, former Chief,of the Texas Attorney ... & Budd, P.C., as Special Counsel in the ... the firm,s Qui Tam litigation team, representing,government entities ... public through corporate fraud., O,Connell served in ...
... Diagnostic Imaging Management Services for SWHP, DEERFIELD, ... operating subsidiary of WellPoint, Inc. (NYSE: WLP ... company with health,plan clients representing over 20 million ... provide a radiology quality program around,diagnostic imaging services ...
Cached Medicine News:Health News:Sutter Regional Medical Foundation Opens New Fairfield Care Center 2Health News:Having Twin Sister Boosts Men's Anorexia Risk 2Health News:New upper limit defined for normal ALT in adolescent males 2Health News:HealthMetrix Research Finds Medicare Advantage Plans Offer Seniors Opportunity to Lower Their 2008 Out-of-Pocket Drug Costs 2Health News:HealthMetrix Research Finds Medicare Advantage Plans Offer Seniors Opportunity to Lower Their 2008 Out-of-Pocket Drug Costs 3Health News:Former Texas Assistant Attorney General Pat O'Connell Joins Baron & Budd, P.C., to Lead Whistleblower Litigation Practice 2Health News:American Imaging Management Enters into Agreement with Scott & White Health Plan 2
VascoTwist is a low profile unipolar permanent pacing lead with a retractable screw. Due to advanced technology VascoTwist 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm...
VascoTwist is a low profile unipolar permanent pacing lead with a retractable screw. Due to advanced technology VascoTwist 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
Medicine Products: